Modeling

Introduction


Mathematical models are essential in science for hypothesis formulation, prediction, comprehension of complicated systems, parameter estimation, optimization, and data interpretation. They are risk-free, allowing scientists to learn about potentially harmful conditions. They help analyze data when studies offer sample information and interpret preliminary data to assist scientists in reaching conclusions. These models also act as a scientific language, allowing diverse experts to discuss ideas and progress knowledge.

Our project aims to design a localized intelligent and controlled anti-cancer drug delivery system against carcinoma employing modified bacteria embedded in a hydrogel. To do this, we have done an extensive literature review, and after discussion with our principal investigators- Dr. Ivan Vorobyev and Dr. Ellina Mun, we have chosen the hydrogel based on chitosan and the bacteriocin Colicin E1 as anti-cancer toxin produced by genetically modified bacteria. As the literature shows, the cancer produces elevated amounts of lactate1. That lactate will determine our specificity taken up by the engineered bacteria, leading to the subsequent release of the protein of interest - Colicin E1.

The system consists of the main components: hydrogel and protein.

Hydrogels are three-dimensional networks of hydrophilic polymer chains that absorb and hold water or biological fluids2. The organization of the chitosan-based hydrogel system was the first task of modeling. Our system’s purpose is that we first inject the hydrogel system into the tumor site. After that, the hydrogel would form the crosslinks at the body temperature and solidify there. The bacteria will be encapsulated in the hydrogel network in a mesh-like structure and have pores from which the protein can escape (Figure 1). The pore size will be enough to hold the bacteria in the gel and provide nutrients, necessary metabolites, and lactate needed for Colicin E1 production.

We will modify bacteria that, in response to high lactate levels, start to produce Colicin E1. Details about our plasmid working principle can be found on the Design page. That way, bacteria will produce the Colicin E1 in response to lactate, which is overexpressed in tumors. Colicin E1 is released through the membrane transport protein called porins. Porins are a type of protein that forms channels in the outer membranes of gram-negative bacteria, allowing tiny molecules such as nutrients and waste products to diffuse. Colicin E1 first binds to the outer membrane vitamin B12 receptor protein known as BtuB, which sets off a series of events that eventually leads to the recruitment of the TolC system (Figure 2). The TolC system then creates a pathway for Colicin to travel over the outer membrane and be released into the extracellular environment3.

The model aims to facilitate future laboratory work by predicting experimental outcomes, such as the hydrogel diffusivity and ColE1 concentration in response to lactate, and identifying sensitive factors that may be changed in the laboratory.

Hydrogel

In hydrogel, by modeling, we can also predict the value of the mesh and pore sizes. The Colicin will be released through pores, while the bacteria will be kept in. These variables could be easily adjusted based on what outcomes we want to achieve. Therefore, it is helpful for our laboratory work and other teams with related projects.

Protein

The system may be optimized to a ColE1 concentration within the therapeutic window by changing the model's parameters. The number of experiments may also be decreased, and the experiment settings can be improved by changing the sensitive parameter values and concentrations. These factors enable the experimental work to be efficient. We do this to support our ongoing study and the work of other investigators who use the modified bacteria in a hydrogel system.




The overexpression of the receptor for vitamin B12 has been observed in several human tumors, such as ovarian, renal, uterine, testicular, cerebral, colonic, pulmonary, and myelocytic neoplasms4. Therefore, ColE1 binds to the vitamin B12 receptors BtuB. Colicin E1 employs BtuB as a receptor for translocation through the outer membrane and the periplasmic space. It permeabilizes the inner membrane by forming pores, decreasing the electrochemical membrane potential and, eventually, cell death5 (Figure 2). Colicin E1 kills cancer cells with no ColE1 plasmid but the appropriate receptor BtuB by forming pores, or ion channels, into the inner membrane6. Colicin cytotoxic action may be exerted on E. coli or some mammalian cells7. Bacteria can avoid lysis by releasing an immunity protein, which protects them from bacteriocin's lethal effects. ColE1 immunity proteins, constitutively generated by natural colicinogenic plasmids, bind to and inactivate cytotoxic domains, preventing intracellular colicin from affecting the cell's activities by blocking its active site8.




The mechanism of action of ColE1 to fight against cancer cells is predicted using an Ordinary differential equation (ODE). The simulation is illustrated in Figure 2. A mathematical equation known as an ODE explains the connection between a function and its derivatives. We aim to comprehend better how the modified plasmid behaves in the hydrogel system. An ODE model may simulate our signaling pathway and forecast the system's behavior over time through transcription equations.

Through implementing matlab simbiology, we have predicted the production of ColicinE1 and related proteins in response to lactate in our engineered plasmid. It helped us to predict the amounts of ColE1 when applied to the tumor site. Thus, we can effectively regulate the concentration to achieve carcinoma treatment.

It is crucial to comprehend and manage diffusivity inside gel-like substances to achieve desired results and maximize the system's functionality. The features of the gel, such as its composition, cross-linking density, and pore size, may be modified to adapt diffusivity to the demands of the particular application. Using diffusivity equations, we have obtained various parameters determining the mesh size. By modeling such parameters, we help ourselves and future teams implement hydrogel of a similar composition to adjust the mesh size of the polymer according to their needs. We have also used Matlab graphs to illustrate the relation of the diffusivity to the solute radius at various concentrations of one of the hydrogel components - hyaluronic acid.

The outcomes anticipated by the model can guide further experiments with the modified bacteria hydrogel system. The model may be altered. Therefore, various parameters and concentrations must be altered when a new receptor or therapeutic protein is utilized.

Conclusion


According to the hydrogel diffusivity graphs obtained, several assumptions could be made about the possible changes in our hydrogel after supplementing the different concentrations of the Hyaluronic Acid. Firstly, the most important one is that HA acid will increase the range of the solute radius, where hydrogel will have effective diffusivity. Secondly, the values of the effective diffusivity will be higher in comparison to the pure chitosan. Even though some of the parameters are approximations of actual values, we found the general trend of the hydrogel behavior of the hydrogel with different recipes. We hope that these findings will be developed in future projects

The average % load of the hydrogel with bacteria fluctuates around 1% depending on the tumor tissues' shape and size. This is a much lower value than the swelling capacity of hydrogels that have similar molecular composition to the hydrogel we use for our system, so there is a relatively low probability of bacterial leakage into the external environment from the hydrogel. The viability of the project is satisfactory.

The protein model meets the expected results of the Colicin E1 production pattern exhibited in the transformed E.coli BL21 (DE3) bacteria. The central dogma of molecular biology was conserved along the process of modeling. We received satisfactory results proving our system's viability and that it can be implemented in real-life personalized cancer treatment. In addition, modeling the protein synthesis and identifying the tumor surface area and volume allowed us to identify if our project is feasible for living organisms. As the results present, the loading of the hydrogel with bacteria is about nine times lower than the maximum swelling capacity of the hydrogel, which is why the risks of bacterial leakage and immune responses are minimal.

1. Trapotsis, A. (2023, September 26). Biosafety levels 1, 2, 3 & 4: What’s the difference? Consolidated Sterilizer Systems. https://consteril.com/biosafety-levels-difference/

2. Cornell University. (n.d.). Non-pathogenic escherichia coli strains biological agent reference sheet (bars). Non-pathogenic Escherichia coli Strains Biological Agent Reference Sheet (BARS) | Environment, Health and Safety. https://ehs.cornell.edu/research-safety/biosafety-biosecurity/biological-safety-manuals-and-other-documents/bars-other/non-pathogenic-escherichia-coli

3. Uc Santa Cruz. (2019). Ethidium bromide. https://ehs.ucsc.edu/lab-safety-manual/specialty-chemicals/ethidium-bromide.html

4. Ahmadi, F., Oveisi, Z., Samani, S. M., & Amoozgar, Z. (2015). Chitosan based hydrogels: characteristics and pharmaceutical applications. Research in Pharmaceutical Sciences, 10(1), 1–16. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26430453

5. Schwartz, S. A., & Helinski, D. R. (1971). Purification and characterization of Colicin E1. Journal of Biological Chemistry, 246(20), 6318–6327. https://doi.org/10.1016/s0021-9258(18)61791-0

6. Van der Poll, T., & Opal, S. M. (2008). Host–pathogen interactions in sepsis. The Lancet infectious diseases, 8(1), 32-43. DOI: 10.1016/S1473- 3099(07)70265-7

7. Galanos, C., & Freudenberg, M. A. (1993). Bacterial endotoxins: biological properties and mechanisms of action. Mediators of inflammation, 2(7), S11–S16. https://doi.org/10.1155/S0962935193000687

8. Axpe, E., Chan, D., Offeddu, G. S., Chang, Y., Mérida, D., Hernandez, H. L., & Appel, E. A. (2019). A multiscale model for solute diffusion in hydrogels. Macromolecules, 52(18), 6889–6897. https://doi.org/10.1021/acs.macromol.9b00753

9. Campbell, K. T., Wysoczynski, K., Hadley, D. J., & Silva, E. A. (2019). Computational-Based Design of Hydrogels with Predictable Mesh Properties. ACS Biomaterials Science & Engineering, 6(1), 308–319. https://doi.org/10.1021/acsbiomaterials.9b01520

10. Kang, Y., Zhao, X., Han, X., Ji, X., Chen, Q., Pasch, H., Lederer, A., & Liu, Y. (2021). Conformation and persistence length of chitosan in aqueous solutions of different ionic strengths via asymmetric flow field-flow fractionation. Carbohydrate Polymers, 271, 118402. https://doi.org/10.1016/j.carbpol.2021.118402

11. Yang, T. (2012). Mechanical and swelling properties of hydrogels [Doctoral thesis, comprehensive summary]. KTH, School of Chemical Science and Engineering (CHE), Fibre and Polymer Technology, Coating Technology.

12. Zhang, W., Jin, X., Li, H., Zhang, R., & Wu, C. (2018). Injectable and body temperature sensitive hydrogels based on chitosan and hyaluronic acid for pH sensitive drug release. Carbohydrate Polymers, 186, 82–90. https://doi.org/10.1016/j.carbpol.2018.01.008

13. Tory, M. C., & Merrill, A. R. (1999). Adventures in Membrane Protein Topology. Journal of Biological Chemistry, 274(35), 24539–24549. https://doi.org/10.1074/jbc.274.35.24539

14. Chen, Y., Yang, S., Zhang, T., Xu, M., Zhao, J., Zeng, M., Sun, K., Yang, R. F. Z., Zhang, P., Wang, B., & Cao, X. (2022). Positron annihilation study of chitosan and its derived carbon/pillared montmorillonite clay stabilized Pd species nanocomposites. Polymer Testing, 114, 107689. https://doi.org/10.1016/j.polymertesting.2022.107689

15. Grillet, A., Wyatt, N. B., & Gloe, L. M. (2012). Polymer gel rheology and adhesion. In InTech eBooks. https://doi.org/10.5772/36975

16. Snetkov, P., Zakharova, K., Морозкина, С. Н., Olekhnovich, R., & Uspenskaya, M. V. (2020). Hyaluronic acid: the influence of molecular weight on structural, physical, Physico-Chemical, and degradable properties of biopolymer. Polymers, 12(8), 1800. https://doi.org/10.3390/polym12081800

17. β-Glycerophosphate disodium salt hydrate. (n.d.). https://www.sigmaaldrich.com/. Retrieved October 10, 2023, from https://www.sigmaaldrich.com/KZ/en/product/sigma/g5422

18. Wang, Z., Ding, B., Zhao, Y., Han, Y., Yu, S., Tao, L., Shen, X., Zhou, J., Jiang, L., & Ding, Y. (2022). Tumor-oriented mathematical models in hydrogel regulation for precise topical administration regimens. Journal of Controlled Release, 345, 610–624. https://doi.org/10.1016/j.jconrel.2022.03.042

19. Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts. (2001). PubMed. https://pubmed.ncbi.nlm.nih.gov/11232863/#:~:text=We%20detected%20clear%20reduction%20of,0.5%2D1.25%20microg%2Fml.

20. Han, Q., Wang, J., Wang, T., Gao, X., Wan, Q., & Pei, X. (2018). Preparation and characterization of Chitosan/Β-Glycerophosphate Thermal-Sensitive hydrogel reinforced by graphene oxide. Frontiers in Chemistry, 6. https://doi.org/10.3389/fchem.2018.00565

21. Michaelson, J., Satija, S., Kopans, D., & Michaelson, S. (2003). Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. ResearchGate. https://www.researchgate.net/publication/322402789_Gauging_the_Impact_of_Breast_Carcinoma_Screening_in_Terms_of_Tumor_Size_and_Death_Rate

22. Anzai, T., Kijima, K., Fujimori, M., Nakamoto, S., Ishihama, A., & Shimada, T. (2023). Expanded roles of lactate-sensing LldR in transcription regulation of the Escherichia coli K-12 genome: lactate utilisation and acid resistance. Microbial Genomics, 9(5). https://doi.org/10.1099/mgen.0.001015

23. De La Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., Garcı́a-Carrancá, A., & Manzo-Merino, J. (2019). Lactate in the regulation of tumor microenvironment and therapeutic approaches. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.01143

24. Zúñiga, A., Camacho, M. D., Chang, H., Fristot, E., Mayonove, P., Hani, E., & Bonnet, J. (2021). Engineered l-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments. ACS Synthetic Biology, 10(12), 3527–3536. https://doi.org/10.1021/acssynbio.1c00456

25. Heyde, S. a. H., & Nørholm, M. H. H. (2021). Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity. Communications Biology, 4(1). https://doi.org/10.1038/s42003-021-02493-4

26. Wang, X., Xu, P., Yao, Z., Fang, Q., Feng, L., Guo, R., & Cheng, B. (2019). Preparation of antimicrobial hyaluronic Acid/Quaternized chitosan hydrogels for the promotion of Seawater-Immersion wound healing. Frontiers in Bioengineering and Biotechnology, 7. https://doi.org/10.3389/fbioe.2019.00360

27. Wang, M., Zhang, J., Xu, H., & Golding, I. (2019). Measuring transcription at a single gene copy reveals hidden drivers of bacterial individuality. Nature Microbiology, 4(12), 2118–2127. https://doi.org/10.1038/s41564-019-0553-z

28. Philips, R. M. &. R. (n.d.). » What is faster, transcription or translation? http://book.bionumbers.org/what-is-faster-transcription-or-translation/

29. Expasy - ProtParam tool. (n.d.). https://web.expasy.org/protparam/

Hydrogel


Model structure

In order to predict the diffusivity of the solute in the hydrogel, we used the Multiscale Model for Solute Diffusion in Hydrogels (MDSM) [8] and MATLAB software to visualize the results.

Model description

The diffusivity of hydrogel plays a crucial role in the determination of the escape rate solute embedded in it. As our project involves the encapsulation of bacteria that synthesize the anti-cancer drug Colicin E1, the efficient diffusion of the drug is pivotal. As several factors affect the diffusivity of the hydrogel in our project, determination of the optimal concentration of the reagents needs to be determined first.

Model construction methods

The diffusivity of hydrogel is calculated using the following formula:


The diffusivity value depends on different variables, including the mesh size of the hydrogel. The hydrogel used in our experiment consists of 3 main ingredients - protasan Cl214, Hyaluronic acid and beta-glycerophosphate disodium salt. According to our predictions, the mesh size should be decreased because of the Hyaluronic acid and beta-glycerophosphate disodium salt. In the modeling part, we decided to calculate the hydrogel mesh size with and without these components and compare them. Firstly, we should find the mesh size of the hydrogel based only on the protasan Cl214.

The mesh size of the polymers [9]:

Where Q is the swelling ratio of the hydrogel, l is the Kuhn length of the repeating unit (45nm [10]), Cn is the determined characteristic ratio (4.0 [11]), Mris the Molecular weight of the repeating unit (1526.464 g/mol), and MC is the molecular weight between cross-links.

While some parameters can be determined from scientific sources, other values should be obtained from calculations.

The swelling ratio of the hydrogel [9]:



Where Ws - is a wet weight which is the amount of the chemical found in subsequent analysis is expressed as the weight of the chemical divided by the total weight, including any water present, of the material which once contained it. WD is dry weight, normal weight without any extra fluid in the body. W is the density of water, and P is the density of the polymer. (The determined value of the density of the protasan Cl214 is 1.387 mg/ml).

The swelling ratio of hydrogel only with protasan is approximately - 1.04623.

Molecular weight between cross-links [9]:



Cp is polymer concentration, R is Gas constant, T is measurement temperature, and G’ is storage modulus. The storage modulus of the hydrogel can be determined only through the experimental method; however, we found the research done on almost similar hydrogel made by chitosan and HA [12]. According to the data from this experiment, the hydrogel that was purely made without HA has the approximate value of the gelation time equal to 100s. The value of the storage modulus of the stable hydrogel was 471 Pa. Relying on these data, we can calculate the molecular weight between cross-links:



After finding these values, we can now calculate the value of the mesh size:



Now when we find the value of the mesh size, we can go to the diffusivity.


The radius of the solute which is colicin E1 is between 21–23 Å. [13] Radius of the free volume of pure chitosan 0.288 nm [14].

However, when the value of the mesh size is much larger than the value of the radius of the solute, the formula for the diffusivity decreases into the following equation, where the polymer volume fraction of chitosan is p - 0.035 [15]:





Diffusivity of hydrogel with different concentrations of HA
After finding the diffusivity of the pure chitosan, we can consider the hydrogel's diffusivity with other components we used. The final hydrogel version is made from protasan CL214, Hyaluronic acid (1%, 2%, 3%) and beta-glycerophosphate disodium salt.

The mesh size is the central aspect of the hydrogel that changes these components. So, we should calculate it with the new variables. The changing variables in calculating the Mesh size are storage modulus and molecular weight of the repeating unit, so according to the equation, we can focus on the



We can calculate the mesh size value at different HA concentrations by finding the change in this parameter. According to the source, storage modulus at 1%, 2%, and 3% of HA is - 617 Pa, 1130 Pa and 2430 Pa, respectively. The molecular weight of HA - is 6000 kg/mo [16], Salt - 216.04 g/mol [17]. So, the average molecular weight of the repeating unit Mr = 238.8 kg/mol. Mc will change according to the concentration of HA.

Table 1. The relation between Hyaluronic Acid concentrations and molecular weight between cross-links
HA Concentration Molecular Weight Between Cross-Links (kg/mol)
1% 4.047
2% 2.210
3% 1.028


By using these data, we can find the mesh size at different concentrations of the HA.

HA Concentration Mesh size, m
1% 1.570*10-8
2% 1.224*10-8
3% 0.835* 10-8


Now, to find the hydrogel's diffusivity, we should consider that the mesh size and the radius of the solute are comparable so that we can use a different equation.


The surface area of the tumor and volume of the gel required:

As the project aims to create a personalized way to treat early-stage carcinomas efficiently and with minimal side effects, we needed to identify the concentrations of bacteria that will be introduced to the hydrogel to produce the Colicin E1 toxin.

To find out these values, we needed to identify the surface area and the volume of the tumor tissue that will get injected with the hydrogel. First, we needed to choose mathematical models for volume and surface area approximation. To approximate the volume and surface area of tumors smaller than 10mm in diameter, we decided to use a right sphere and to approximate the volume and surface area of tumors over 10mm in diameter; we decided to use a bipyramid. The surface area and volume of a sphere are calculated with the usage of the following formulas:






To determine larger tumoral tissues' surface area and volume, we used a bipyramidal model with two main measurements - length (b) and width (a).






H is the height of a single face, calculated using the following formula:



The surface area of the approximated figure corresponds to the surface area that should be covered with hydrogel with encapsulated bacteria inside of it. The next step is to determine the hydrogel volume that should be administered to cover the particular surface area of the tumor tissue. There is a linear correlation between the volume of the hydrogel (V adm) and the surface area it covers, which is described by the following formula:



Now, as we know the volume of the hydrogel that will be used to treat the particular surface area of the tumor, as well as we know the volume of the tumor, we can calculate the overall volume of the system. The overall volume is the sum of all volumes:



The system's overall volume will give us information about the required amount of the toxin to obtain the concentration of the toxin that would be cytotoxic to the cancer cells. The concentration usually mentioned in the literature equals 1.25 ug/ml [19].

Now, we need to convert this concentration into molar concentration to calculate the number of bacteria required to be encapsulated in the hydrogel because the maximum concentration of the toxin they produce is given in the molar range.



This is the cytotoxic concentration of the drug that should be maintained in the whole system during the tumour treatment. Now, we will use this concentration to identify the volume of the bacteria that should be injected into the hydrogel to obtain the needed concentration:



The correlation between the volume of bacteria and the concentration of Colicin E1 they produce depends on different molecular processes such as transcription, translation, and toxin translocation. This part of the modeling is described in more detail on this page afterwards. For now, we will omit these calculations and instead get the obtained values from the ordinary differential equations.

It is also assumed that the concentration of bacteria in the given volume fluctuates in a constant range because the bacteria are encapsulated in the hydrogel. Therefore, their proliferation rate is decreased, so the division rate is presumed to be equal to the death rate.

The volume of the encapsulated bacteria allows us to calculate the percentage of the bacteria in the whole hydrogel-bacteria system, which will help us evaluate the system's viability. According to the literature review, the swelling capacity of the hydrogel with similar chemical composition equals 9.23 %[20]. So, if the percentage of hydrogel loading exceeds its swelling capacity, the bacteria and the toxin would not be contented in the hydrogel, and bacterial leakage might occur.



Overall, modeling the tumour's surface area allows us to estimate the hydrogel volume that should be injected into the tumor site to cover the tumor completely and obtain the expected efficiency of the treatment. We also obtain information about what volume of bacteria we need to encapsulate to maintain the cytotoxic concentration of tumor cells. These calculations and modeling simplify the procedure of the final system preparation and the need for experiments, as well as provide personalized treatment approaches to the patients.

Protein


Model structure

The model was composed in MATLAB Simbiology extension, using Ordinary Differential Equations (ODEs) as the basis for the modulation of processes of Colicin E1 synthesis at tumor sites. The model is mainly built on the synthesis of colicin E1 in response to the presence of lactate in the environment, which is a main product of tumor cell metabolism due to the Warburg effect.

Model description




The visual illustration of the model process at tumor sites is depicted in Figure 4. As lactate enters bacteria cells (1), it acts as a stimulator of colicin E1 mRNA transcription via dissociation of hairpin formed by the LldR protein encoded in our plasmid (2). This allows the T7 RNA Polymerase to bind the P11 promoter of the plasmid (3) and proceed to the transcription phase (4). Following that, the colicin E1 mRNA is translated into colicin E1 protein (5), and it escapes the bacteria cell (6) and leads to the apoptosis of cancer cells (7). This leads to a decrease in lactate in the environment (8) and colicin E1 synthesis.

LldR is commonly known as a lactate-responsive transcription factor that regulates the transcription of genes in response to the presence of lactate in the environment [22]. In our plasmid, LldR regulates the transcription of the colicin E1 through binding to O1 and O2 binding sites, opening up the P11 promoter.

As colicin E1 accumulates at the tumor site and reaches its effective concentration, it affects the cancer cells and could decrease their population by up to 43% in 24 hours [23]. Cancer cell depletion has an effect on lactate concentration in the environment. Thus, it downregulates the synthesis of colicin E1, creating a loop.

Model construction methods:

The solver type used in the simulation is ode15s, and reactions are primarily Mass-Action, with several exceptions being set at Unknown. Besides ODEs, the model also has repeated assignments. The model comprises 5 ODEs and 2 repeated assignments, demonstrating rates of synthesis and degradation of colicin E1, its effects on tumor site depletion and a negative feedback loop of DNA replication regulation produced by the effect of Colicin E1 on decreasing lactate production.

As stated above, most reactions use Mass-Action models, and some use repeated assignments. Repeated assignments are dedicated to the control and change of the molecules in time, which do not participate in the reactions explicitly nor are consumed during the reactions.

The reactions used in the model were defined from scratch, based on the ODEs engineering webinar series from iGEM. The values used in the model for equations were derived from the literature or manually due to the need for concrete information on specific constants.

The model consists of three compartments representing:
a. Tumor site - given the average volume of cancer, the bacteria will target in a hydrogel we plan to inject.
b. Environment - which consists of the bacteria and hydrogel. It shows the volume in which the toxin will spread.
c. Bacteria (in our case, E.coli BL21 (DE3)) - the volume of bacteria that will be encapsulated in hydrogel to inject further and synthesize colicin E1.
The limiting factor of colicin E1 synthesis in our model is considered to be lactate. The initial lactate value in the environment was assumed to be 20 mM, referring to the available literature [23].

Assumptions

The model our team proposes has three major assumptions we had to take to make our model realistic:

1. The lactate concentration. It is stated through the literature that lactate concentration varies in tumor sites from 10 mM to 30 mM [23], and given that we have this data, it was assumed that the lactate concentration in tumor sites, on average, is 20 mM.
2. The number of plasmid copies transformed in E.coli BL21 (DE3). Since our plasmid is based on pET9a plasmid, defined as low-copy, we assume the copy number in bacteria to be 5 [24]
3. The amount of bacteria in the simulated model.

The value for bacteria number is assumed to be constant since the strain used in the simulation is mainly oriented on transcription and not replication[25]; furthermore, the hydrogel possesses a little toxicity to bacterial cells due to hyaluronic acid in the structure [26].

Initial Conditions

Abbreviation Full name Value Units Source
Environment Tumor site Environment 965 uL -
E.coli E.coli BL21 (DE3) 5 uL -
Tumor Tumor cells 524 uL -
ColE1_env Colicin E1 in Environment 0 M -
Lactate_IN Lactate inside E.coli BL21 (DE3) 20 mM [23]
LldR LldR protein in E.coli BL21 (DE3) 4.4 x 10-9 M Calculated
P11 P11 promoter 4.4 x 10-9 M Calculated
ColE1mRNA Colicin E1 mRNA 0 M -
T7 T7 polymerase 4.98 x 10-6 M -
ColE1 Colicin E1 in E.coli BL21 (DE3) 0 M -


Parameters

table { border-collapse: collapse; width: 50%; margin: 0 auto; } th, td { border: 1px solid #ccc; padding: 8px; text-align: center; } th { background-color: #f0f0f0; }
Abbreviation Full name Value Units Source
k_1 LldR and lactate affinity value 0.8 uL -
k_2 P11 promoter release rate from LldR 1 - Assumption
kf_0 Colicin E1 mRNA degradation rate 0.0078 1/s [27]
kf_1 Colicin E1 translation rate 0.0383 1/s [28]
kf_2 Colicin E1 degradation rate 0.069 1/s [29]
kf_3 Colicin E1 escape rate from bacteria 1 1/s Assumption
kf_4 Colicin E1 mRNA transcription rate 0.1147 1/(M/s) [28]
kf_5 Rate of lactate decrease 0.0238 1/hour [19]
k_ColE1_threshold Efficient anti-tumor concentration of Colicin E1 2.19 x 10-8 M [19]


Reaction equations

ODEs:




Hydrogel


Model validation










The diffusivity of hydrogel at changing concentrations of Hyaluronic Acid at 1%, 2% and 3% can be seen in Figure 5, Figure 6, and Figure 7. The obtained results suggest the decrease in the initial diffusivity rates of the solute from the hydrogel, demonstrating the efficiency of increasing the Hyaluronic Acid concentration in hydrogel composition in preventing solute escape.

Spherical approximation:




The graph represents the hydrogel volume that should be administered to cover tumors of a particular surface area. In this plot, the independent variable is the radius of the tumor only. Now, as we can visualize the volume of the hydrogel we need, we can identify the total volume of the system containing the tumor, and the hydrogel with bacteria (This is for spherical approximation.)




Bipyramidal Approximation:

The following graph shows the dependence of the volume that should be administered to the tumor site of a particular dimension. It should be noted that in the case of bipyramidal approximation, there are two independent variables, the larger and the smaller radiuses of the tumor, which are transformed into the height of the bipyramide and the length of the base of the bipyramide, respectively. However, on the graph, only the change in height is shown, although the length is also changing from 6.5 to 10 mm, compatible with the average measurement values of the tumors, as described at the beginning.




Knowing the volume of the hydrogel needed, we can deduce the system's total volume with respect to a particular dimension of the tumor. Further, it will be needed to calculate the amount of the toxin and bacteria that should be encapsulated into the hydrogel.




Now, as we know the system's total volume, we can calculate the volume of the bacteria that has to be encapsulated to produce Colicin E1 up to the cytotoxic concentration.

As the volume of the bacteria needed to be encapsulated into the hydrogel to produce a certain amount of Colicin E1 depends on the ordinary differential equations, and the whole system was constructed using MatLab Software, it is barely possible to derive a function that is dependent on only variable - the volume of the tumor in our case. So, to represent the results, a tumor tissue model with a 10mm diameter, approximated as a sphere, was taken as an example to show the mechanism of how personalized calculations should be accomplished.

Firstly, the volume and surface area of a tumor is identified using the formula mentioned in the Methods section:

Vtumor = (4/3) * π * r3 = (4/3) * π * 53 ≈ 524 μL

SAtumor = 4 * π * r2 = 4 * π * 52 ≈ 314 mm2

For now, we can find the volume of the hydrogel needed to be injected into the tumor site to cover it completely. The volume of the hydrogel would be:

Vhydrogel = -0.5533 + 1.4087 * SAtumor = -0.5533 + 1.4087 * 314 ≈ 442 μL

Now, we will find the total volume of the system, in which the required concentration should be obtained.

Vtotal = Vhydrogel + Vtumor = 442 + 524 = 966 μL

To identify the volume of bacteria needed, we refer to MatLab Simbiology.

To produce the required amount of Colicin E1 in the volume of 966 uL, we need to incorporate 5 uL of the transformed bacteria.

966 μL with 21.9 nM → 5 μL of bacteria

So, the % load of the hydrogel can be calculated now:

% load = Vbacteria / (Vbacteria + Vhydrogel) * 100% = 1.119%


The exact calculation of the % load can be done with the bipyramidal approximation:
Let us assume that we need to identify the volume of bacteria and the % load of the hydrogel to cover a tumor with a length of 17 mm and a width of 12 mm, the maximum dimensions of an early-stage tumor [21].
We will mainly use the same formulas used in the previous case; however, we will change the formulas for finding the tumor tissue's volume and surface area.

The volume and surface area of the tumor with such dimensions would be:
Vtumor=1/3 *a2*b=1/3*122*17=816 L

SAtumor= 4*a*h=4*12*10.40499 mm2

Now, the volume of the hydrogel to cover the particular surface area of the tumor is calculated:

Vhydrogel=-0.5533+1.4087*499=702 L

Total volume of the system is the sum of the hydrogel volume and the volume of the tumor:

Vtotal= 702+816=1518 L

Now, we can use the MatLab Software to deduce the volume of the bacteria to be loaded into the hydrogel, to obtain the cytotoxic concentration:

21.9 nM in 1518 L 7.8 L of bacteria

So, the % load of the hydrogel is:

% load=7.8/(7.8+702)*100%= 1.09%


Protein


Model validation

The modeling was performed, and several parameters were evaluated to validate the model. The plots of Colicin E1 production, Colicin E1 mRNA transcription, and lactate concentration change over time




The concentration rate changes of Colicin E1 mRNA are demonstrated above, and the mRNA rises to 22.5 nM, gradually degrading. The concentration of mRNA of Colicin E1 demonstrates a high rate of initial production, which is due to the nature of the E.coli BL21 (DE3) strain that can produce a large amount of mRNA. E.coli BL21 (DE3) contains the plasmid encoding the sequence for T7 RNA Polymerase under the control of a stronger version of lacZ promoter, lacUV5 promoter. Afterwards, the concentration of mRNA starts to fall due to the degradation of mRNA. Also, as ColE1mRNA is synthesized, it leads to the production of Colicin E1 protein, which potentially would kill tumor cells producing the lactate, a natural inducer of lldR operon.




Figure 13 represents the rate of Colicin E1 synthesis in E.coli BL21 (DE3) species in tumor sites in response to the present lactate concentration. The plot reached its maximum at around 21.5 nM. Then, it slumped until it reached its minimal concentration of 0 M. This is achieved due to the optimal expression rate of the protein and low copy number of plasmids transformed in the bacteria; the over- and underexpression of Colicin E1 was avoided. Another factor that contributed to the obtained results was the capability to adjust the volume of injected bacteria to the tumor site, giving us flexibility in regulating this variable.




As Colicin E1 reaches its effective concentration, it will affect the lactate concentration in the tumor microenvironment. This will decrease lactate production, which further negatively affects the production of Colicin E1. This implies that after the lactate reaches its minimal concentration, the synthesis of Colicin E1 will drop. Thus, the loop of its production will not continue indefinitely

Improvements:

The model could be further extended by implementing a negative feedback loop on tumor cell lactate synthesis, allowing more precise results. Besides, different compositions of plasmid copy number and promoters could affect the protein synthesis rate, meeting the researchers' needs. In addition to that, there were several restrictive rules in the MATLAB Simbiology Software, which did not allow us to reproduce the genetics of bacteria fully to obtain more accurate and precise results; for example, as it can be known, in living cells, all regulatory pathways and signal cascades are interrelated to each other, and usually produce large networks of reaction. In contrast, in the software we have used, each species could be affected by a limited number of reaction or rate rules. To avoid such misrepresentations, more advanced biological software could have been used.